These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 23762454)
1. Electrophysiologic biomarkers for assessing disease progression and the effect of riluzole in SOD1 G93A ALS mice. Li J; Sung M; Rutkove SB PLoS One; 2013; 8(6):e65976. PubMed ID: 23762454 [TBL] [Abstract][Full Text] [Related]
2. Assessing the therapeutic impact of resveratrol in ALS SOD1-G93A mice with electrical impedance myography. Nagy JA; Semple C; Lo P; Rutkove SB Front Neurol; 2022; 13():1059743. PubMed ID: 36619925 [TBL] [Abstract][Full Text] [Related]
3. Single and modeled multifrequency electrical impedance myography parameters and their relationship to force production in the ALS SOD1G93A mouse. Li J; Pacheck A; Sanchez B; Rutkove SB Amyotroph Lateral Scler Frontotemporal Degener; 2016; 17(5-6):397-403. PubMed ID: 27077943 [TBL] [Abstract][Full Text] [Related]
4. Electrical impedance myography for monitoring motor neuron loss in the SOD1 G93A amyotrophic lateral sclerosis rat. Wang LL; Spieker AJ; Li J; Rutkove SB Clin Neurophysiol; 2011 Dec; 122(12):2505-11. PubMed ID: 21612980 [TBL] [Abstract][Full Text] [Related]
5. Electrical impedance myography correlates with standard measures of ALS severity. Rutkove SB; Caress JB; Cartwright MS; Burns TM; Warder J; David WS; Goyal N; Maragakis NJ; Benatar M; Sharma KR; Narayanaswami P; Raynor EM; Watson ML; Shefner JM Muscle Nerve; 2014 Mar; 49(3):441-3. PubMed ID: 24273034 [TBL] [Abstract][Full Text] [Related]
6. n-butylidenephthalide treatment prolongs life span and attenuates motor neuron loss in SOD1 Zhou QM; Zhang JJ; Li S; Chen S; Le WD CNS Neurosci Ther; 2017 May; 23(5):375-385. PubMed ID: 28229532 [TBL] [Abstract][Full Text] [Related]
7. Early interneuron dysfunction in ALS: insights from a mutant sod1 zebrafish model. McGown A; McDearmid JR; Panagiotaki N; Tong H; Al Mashhadi S; Redhead N; Lyon AN; Beattie CE; Shaw PJ; Ramesh TM Ann Neurol; 2013 Feb; 73(2):246-58. PubMed ID: 23281025 [TBL] [Abstract][Full Text] [Related]
8. Combined riluzole and sodium phenylbutyrate therapy in transgenic amyotrophic lateral sclerosis mice. Del Signore SJ; Amante DJ; Kim J; Stack EC; Goodrich S; Cormier K; Smith K; Cudkowicz ME; Ferrante RJ Amyotroph Lateral Scler; 2009 Apr; 10(2):85-94. PubMed ID: 18618304 [TBL] [Abstract][Full Text] [Related]
9. Impaired spinal cord glutamate transport capacity and reduced sensitivity to riluzole in a transgenic superoxide dismutase mutant rat model of amyotrophic lateral sclerosis. Dunlop J; Beal McIlvain H; She Y; Howland DS J Neurosci; 2003 Mar; 23(5):1688-96. PubMed ID: 12629173 [TBL] [Abstract][Full Text] [Related]
10. Pre-symptomatic detection of chronic motor deficits and genotype prediction in congenic B6.SOD1(G93A) ALS mouse model. Hayworth CR; Gonzalez-Lima F Neuroscience; 2009 Dec; 164(3):975-85. PubMed ID: 19699279 [TBL] [Abstract][Full Text] [Related]
11. Multi-dimensional electrical impedance myography of the tongue as a potential biomarker for amyotrophic lateral sclerosis. Alix JJP; McDonough HE; Sonbas B; French SJ; Rao DG; Kadirkamanathan V; McDermott CJ; Healey TJ; Shaw PJ Clin Neurophysiol; 2020 Apr; 131(4):799-808. PubMed ID: 32066098 [TBL] [Abstract][Full Text] [Related]
12. Motor unit number estimation predicts disease onset and survival in a transgenic mouse model of amyotrophic lateral sclerosis. Shefner JM; Cudkowicz M; Brown RH Muscle Nerve; 2006 Nov; 34(5):603-7. PubMed ID: 16892429 [TBL] [Abstract][Full Text] [Related]
13. Riluzole does not improve lifespan or motor function in three ALS mouse models. Hogg MC; Halang L; Woods I; Coughlan KS; Prehn JHM Amyotroph Lateral Scler Frontotemporal Degener; 2018 Aug; 19(5-6):438-445. PubMed ID: 29221425 [TBL] [Abstract][Full Text] [Related]
14. Fasudil, a rho kinase inhibitor, limits motor neuron loss in experimental models of amyotrophic lateral sclerosis. Takata M; Tanaka H; Kimura M; Nagahara Y; Tanaka K; Kawasaki K; Seto M; Tsuruma K; Shimazawa M; Hara H Br J Pharmacol; 2013 Sep; 170(2):341-51. PubMed ID: 23763343 [TBL] [Abstract][Full Text] [Related]
15. Effect of neurophilin ligands on motor units in mice with SOD1 ALS mutations. Shefner JM; Brown RH; Cole D; Chaturvedi P; Schoenfeld D; Pastuszak K; Matthews R; Upton-Rice M; Cudkowicz ME Neurology; 2001 Nov; 57(10):1857-61. PubMed ID: 11723276 [TBL] [Abstract][Full Text] [Related]
16. A technique for performing electrical impedance myography in the mouse hind limb: data in normal and ALS SOD1 G93A animals. Li J; Staats WL; Spieker A; Sung M; Rutkove SB PLoS One; 2012; 7(9):e45004. PubMed ID: 23028733 [TBL] [Abstract][Full Text] [Related]
17. Reducing sample size requirements for future ALS clinical trials with a dedicated electrical impedance myography system. Shefner JM; Rutkove SB; Caress JB; Benatar M; David WS; Cartwright MS; Macklin EA; Bohorquez JL Amyotroph Lateral Scler Frontotemporal Degener; 2018 Nov; 19(7-8):555-561. PubMed ID: 30265154 [TBL] [Abstract][Full Text] [Related]
18. Influence of methylene blue on microglia-induced inflammation and motor neuron degeneration in the SOD1(G93A) model for ALS. Dibaj P; Zschüntzsch J; Steffens H; Scheffel J; Göricke B; Weishaupt JH; Le Meur K; Kirchhoff F; Hanisch UK; Schomburg ED; Neusch C PLoS One; 2012; 7(8):e43963. PubMed ID: 22952827 [TBL] [Abstract][Full Text] [Related]
19. Riluzole preserves motor function in a transgenic model of familial amyotrophic lateral sclerosis. Gurney ME; Fleck TJ; Himes CS; Hall ED Neurology; 1998 Jan; 50(1):62-6. PubMed ID: 9443458 [TBL] [Abstract][Full Text] [Related]